EKSOEkso Bionics Holdings, Inc.

$29M

Q1 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3M+34.4% YoY

Gross Profit

$1M47.1% margin

Operating Income

-$4M-165.1% margin

Net Income

-$5M-180.0% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

-37.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$563,000

Balance Sheet

Total Assets

$44M

Total Liabilities

$11M

Stockholders' Equity

$33M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+34.4%
Gross Profit	$1M	$1M	-2.1%
Operating Income	-$4M	-$3M	-35.0%
Net Income	-$5M	-$4M	-25.9%

Revenue Segments

Royalty

$280,000100%

Geographic Segments

Americas

$1M27%

UNITED STATES

$1M26%

Asia Pacific

$605,00012%

EMEA

$564,00011%

EMEA, Other

$440,0009%

JAPAN

$280,0005%

APAC, Other

$277,0005%

GERMANY

$124,0002%

Americas, Other

$55,0001%

SINGAPORE

$48,0001%

EKSO Q1 2022 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena